Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

Journal of Viral Hepatitis
Kosh AgarwalM H Nguyen

Abstract

Vesatolimod is an oral agonist of toll-like receptor 7 designed to minimize systemic exposure and side effects. We assessed the safety and efficacy of vesatolimod in viremic chronic hepatitis B (CHB) patients not currently on oral antiviral treatment (OAV) in a phase 2, multicentre, double-blind, randomized, placebo-controlled study. A total of 192 patients stratified by HBeAg status and alanine aminotransferase level were randomized 2:2:2:1 to receive oral vesatolimod (1-, 2- or 4-mg) or placebo once weekly for 12 weeks; tenofovir disoproxil fumarate (300-mg daily) was administered daily for 48 weeks. Efficacy was assessed by quantitative serum HBsAg decline at Week 24 from baseline. In addition to safety assessments, changes in whole-blood interferon-stimulated gene (ISG) transcripts and serum cytokines were explored. Most patients were male (64.1%) and HBeAg-negative (60.9%) at baseline. Among vesatolimod-treated patients, most (60.4%-69.1%) experienced ≥1 treatment-emergent adverse event; the majority were mild or moderate in severity. No clinically meaningful differences in HBsAg changes from baseline were observed between treatment groups. No patients experienced HBsAg loss, while 3 patients experienced HBeAg loss and hep...Continue Reading

References

Dec 14, 2002·Human Immunology·Andrzej DzionekJürgen Schmitz
Mar 12, 2004·The New England Journal of Medicine·Don Ganem, Alfred M Prince
Mar 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isabelle Béatrice Bekeredjian-DingGunther Hartmann
Aug 17, 2005·The Journal of Experimental Medicine·Carine Asselin-Paturel, Giorgio Trinchieri
Jan 21, 2006·Nature Immunology·Taro Kawai, Shizuo Akira
Dec 22, 2007·Journal of Hepatology·Giovanna FattovichFrancesco Donato
Feb 27, 2010·Journal of Hepatology·Mala K Maini, Anna Schurich
Aug 14, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kathryn M KitrinosMichael D Miller
Nov 26, 2013·The Medical Clinics of North America·Brian J McMahon
Jun 10, 2014·Immunity·Haifeng C XuPhilipp A Lang
Nov 14, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A TerraultUNKNOWN American Association for the Study of Liver Diseases
Apr 22, 2017·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver

❮ Previous
Next ❯

Citations

Jan 10, 2019·Expert Review of Clinical Pharmacology·Lung-Yi MakMan-Fung Yuen
Jul 18, 2020·Current Opinion in HIV and AIDS·Jesper Damsgaard GunstOle Schmeltz Søgaard
Oct 9, 2019·Expert Opinion on Drug Metabolism & Toxicology·Ming-Lun YehWan-Long Chuang
Aug 4, 2018·Frontiers in Microbiology·Guangyun TanGenhong Cheng
Jan 3, 2019·Hepatology International·Julia LangRobert Thimme
Oct 13, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sharon A RiddlerDevi SenGupta
Jan 1, 2021·Frontiers in Immunology·Ying Cai, Wenwei Yin
Mar 21, 2021·Clinical and Translational Science·Joseph F GrippoElizabeth Calleja
Apr 13, 2021·Expert Opinion on Therapeutic Targets·Mohube Betty MaepaPatrick Arbuthnot
May 25, 2021·Current Opinion in Virology·Gaëtan LigatThomas F Baumert
Jun 2, 2021·The Journal of Clinical Investigation·Tsung-Yu TsaiShie-Liang Hsieh
May 17, 2021·Current Opinion in Virology·Carolina ChialeMichael D Robek
Jun 3, 2021·Pharmaceuticals·Georgia-Myrto PriftiGrigoris Zoidis
Dec 29, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Oliver E AminLaura J Pallett
Jul 29, 2021·World Journal of Gastrointestinal Pharmacology and Therapeutics·Niraj James ShahKumar Pallav
Sep 3, 2021·Current Opinion in Pharmacology·Lisa Sandmann, Markus Cornberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.